Home Cart 0 Sign in  

[ CAS No. 934524-10-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 934524-10-4
Chemical Structure| 934524-10-4
Structure of 934524-10-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 934524-10-4 ]

Related Doc. of [ 934524-10-4 ]

Alternatived Products of [ 934524-10-4 ]

Product Details of [ 934524-10-4 ]

CAS No. :934524-10-4 MDL No. :MFCD13193624
Formula : C13H9Cl2N3O2S Boiling Point : -
Linear Structure Formula :- InChI Key :DTDGVNQSPAWHTH-UHFFFAOYSA-N
M.W : 342.20 Pubchem ID :53486828
Synonyms :

Calculated chemistry of [ 934524-10-4 ]

Physicochemical Properties

Num. heavy atoms : 21
Num. arom. heavy atoms : 15
Fraction Csp3 : 0.08
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 81.58
TPSA : 73.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.46 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.71
Log Po/w (XLOGP3) : 4.13
Log Po/w (WLOGP) : 4.36
Log Po/w (MLOGP) : 3.05
Log Po/w (SILICOS-IT) : 2.5
Consensus Log Po/w : 3.35

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.96
Solubility : 0.00375 mg/ml ; 0.000011 mol/l
Class : Moderately soluble
Log S (Ali) : -5.37
Solubility : 0.00144 mg/ml ; 0.00000422 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -5.74
Solubility : 0.000621 mg/ml ; 0.00000182 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.69

Safety of [ 934524-10-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 934524-10-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 934524-10-4 ]
  • Downstream synthetic route of [ 934524-10-4 ]

[ 934524-10-4 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 90213-66-4 ]
  • [ 98-59-9 ]
  • [ 934524-10-4 ]
YieldReaction ConditionsOperation in experiment
97% With sodium hydroxide In dichloromethane; water at 18 - 25℃; for 0.5 h; Intermediate 92,4-Dichloro-7-[(4-methylphenyl)sulfonyll-7H-pyrrolo[2,3-(i]pyrimidine2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine (1.00 g, 5.32 mmol), 4-methylbenzene-l-sulfonyl chloride (1.115 g, 5.85 mmol) and tetra-butylammonium hydrogen sulfate (0.090 g, 0.27 mmol) were dissolved in DCM (20 mL) at r.t., and NaOH (50percent aq., 1 mL) was added. The reaction mixture stirred at room temperature for 30 minutes. After completion of the reaction as indicated 103496-1Pby TLC, the reaction mixture diluted with H2O and DCM and separated. The organic layer was evaporated in vacuo to obtain a light yellow solid, which was purified by column chromatography (100percent DCM) to provide the title product (1.76 g, 97percent) as a white solid. LCMS: 342 [M+H] +. 1H NMR (400 MHz, CHLOROFORM-D) δ ppm 8.14 (d, J=8.59 Hz, 2 H) 7.78 (d, J=3.79 Hz, 1 H) 7.39 (d, J=8.59 Hz, 2 H) 6.70 (d, J=3.79 Hz, 1 H) 2.45 (s, 3 H).
95% With sodium hydroxide In water; acetone at 0 - 20℃; EXAMPLE 23-((3No.,4No.)-4-Methyl-3-(d3-methyl(2-dr7H-pyrrolo[2, 3-<;f|pyrimidin-4- yl)amino)piperidin-l-yl)-3-oxopropanenitrile mono citrate salt(CP-690550-6?4 citrate salt)Step 1[00163] 4-Chloro-7-tosyl-7H-pyrrolor2,3-6πpyrimidine: 4-Methylbenzene-l- sulfonyl chloride (3.7 g, 19.32 mmol, 1.20 equiv.) was added to a solution of 2,4- dichloro-7H-pyrrolo[2,3-<;i]pyrimidine 1 (3g, 16.1 mmol, 1.00 equiv.) in acetone (20 mL). At about 0 0C, an aqueous sodium hydroxide solution (2 mol/L, 12mL) was added dropwise to the solution. The solution was then stirred at ambient temperature for about 3 hours. The solids were collected by filtration and washed with acetone/water to give the title product as a white solid (5.2 g; yield = 95percent). LC-MS: m/z = 342 (M+Η)+.
95% With dmap; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2 h; Inert atmosphere A stirred solution of S-1 (2.00 g, 10.7 mmol) in CH2Cl2(20 mL) taken in a round- bottom flask was charged with DIPEA (3.7 mL, 21.4 mmol), DMAP (0.039 g, 0.32 mmol) and p-toluene sulfonyl chloride (2.25 g, 11.7 mmol) successively at ambient temperature under nitrogen atmosphere. The reaction mixture was stirred for 2 h at same temperature. The reaction mixture was diluted with CH2Cl2(100 mL) and was washed with water (40 mL) and HCl (1 N, 40 mL). The combined organic layer was washed with brine (1 × 50 mL), dried over anhydrous Na2SO4and was concentrated under reduced pressure. The obtained residue was washed with hexanes (2 × 50 mL) and was dried under vacuum to afford S-2 (3.50 g, 95percent, AMRI lot IN-SKY-C-03) as an off-white solid. The compound was characterized by1H NMR analysis.1H NMR (400 MHz, CDCl3): δ 8.03 (d, J = 8.4 Hz, 2H), 7.68 (d, J = 4 Hz, 1H), 7.29 (d, J = 8.12 Hz, 2H), 6.60 (d, J = 4 Hz, 1H), 2.36 (s, 3H).
90%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.0833333 h;
Stage #2: at 20℃; for 1 h;
In a flask 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine (1.0 g, 5.3 mmol) in DMF (30 rnL) was added NaH (60percent in mineral oil, 0.21 g, 5.3 mmol). After stirring 5 min at room temperature the reaction mixture was added tosyl chloride (1.0 g, 5.3 mmol) and stirred 1 h at room temperature. The reaction mixture was diluted with H2O (100 mL) and filtered. The filtered solid was washed with H2O (20 mL) and dried 5 h under house vacuum at 80 0C to afford the title compound as a yellow solid (1.6 g, 90percent). 1H NMR (500 MHz, DMSO-d6): δ 2.38 (s, 3H), 6.98 (d, J = 4.1 Hz, IH), 7.50 (d, J = 8.3 Hz, 2H), 8.03 (d, J = 8.5 Hz, 2H), 8.11 (d, J = 4.1 Hz, IH) MS (ES+): m/z 343 (M+H)+
90%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.0833333 h;
Stage #2: at 20℃; for 1 h;
To a solution of 2,4-dichloro-7H-pyrrolo[2,3-J]pyrimidine (1.0 g, 5.3 mmol) in DMF (30 mL) was added NaH (60percent in mineral oil, 0.21 g, 5.3 mmol). The mixture was stirred for 5 min at room temperature and added tosyl chloride (1.0 g, 5.3 mmol). The mixture was stirred for 1 h at room temperature, diluted with H2O (100 mL), and filtered. The solid was washed with H2O (20 mL), and dried under vacuum 5 h at 80 0C to afford the title compound as a yellow solid (1.6 g, 90percent). <n="47"/>[0158] 1H NMR (500 MHz, DMSO-J6): δ 2.38 (s, 3H), 6.98 (d, J = 4.1 Hz, IH), 7.50 (d, J = 8.3 Hz, 2H), 8.03 (d, J = 8.5 Hz, 2H), 8.12 (d, J = 4.1 Hz, IH)[0159] MS (ES+): m/z 342 (M+H)+
89% With dmap; triethylamine In dichloromethane at 20℃; for 5 h; Cooling with ice In the ice bath conditions,A solution of 2,4-dichloro-7H-pyrrole [2,3-d] pyrimidine 1.0 gWas dissolved in 50 mL of dichloromethane,To the above mixed solution, 1.06 g of p-toluenesulfonyl chloride was added slowly,Triethylamine 1.08 g,N, N-dimethylpyridin-4-amine, 0.019 g,The mixed solution was stirred at room temperature for 5 h,After the reaction is complete,To the above solution was poured into 150 mL, the organic phase was washed with water,Citric acid aqueous solution and brine solution were washed three times each. The organic phase was dried with anhydrous magnesium sulfate overnight, and the solvent was evaporated under reduced pressure to obtain crude product.Recrystallization from petroleum ether gave 1.6 g of pure white product.Yield 89percent.
86%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.5 h;
Stage #2: at 20℃;
To a solution of 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine (500 mg, 2.66 mmol) in DMF (5 mL) was added NaH (120 mg, 2.93 mmol, 60percent) at 0 °C, and the mixture was stirred at this temperature for 30 mm. Then paratoluensulfonyl chloride (608 mg, 3.19 mmol) was added to the mixture, and the resulting mixture was stirred at rt overnight. To the reaction mixture was added water (50 mL) to quench the reaction, and the resulting mixture was partitioned. The aqueous layer was extracted with ethyl acetate (50 mL x 2). The combined organic layers were washed with saturated brine (80 mL), dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated in vacuo and the residue was purified by silica gel column chromatography (PE/EtOAc (v/v) = 10/1) to give the title compound as a yellow solid (780 mg, 86 percent).MS (ESI, pos. ion) m/z: 343.90 [M+H]+1H NMR (400 MHz, CDC13) (ppm): 8.13 (d, J = 8.3 Hz, 2H), 7.77 (d, J = 4.0 Hz, 1H), 7.38 (d, J = 8.2 Hz, 2H), 6.70 (d, J = 4.0 Hz, 1H), 2.45 (s, 3H).
84%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.0833333 h;
Stage #2: at 20℃; for 1 h;
To a solution of 2,4-dichloro-7Hpyrrolo[2,3-d]pyrimidine (4.5 g, 23.93 mmol) in DMF (140 mL) was added NaH (0.957g, 23.93 mmol). After stirring for 5 min at room temperature, 4-methylbenzene-1-sulfonyl chloride (4.56 g, 23.93 mmol) was added and the reaction mixture was stirred at room temperature for 1 hour. The mixture was diluted with water (450 mL) and filtered. The solid was washed with water (90 mL) and dried to give the title compound 1a (7 g,84 percent yield) as a white solid. LCMS: 342 [M+H]+.
80% With sodium hydroxide In acetone at 0 - 20℃; for 2 h; After 2,4-dicWoro-7H-pyrrolo[2,3-d]pyrimidine (3.0 g, 16.0 mmol) was dissolved in acetone (20.0 mL), 4- methylbenzenesulfonyl chloride (4.6 g, 23.9 mmol) was added thereto. After cooling to 0 °C, 2 M sodium hydroxide solution (12.0 mL) was slowly added dropwise and then stirred at room temperature for 2 hours. The organic layer was isolated, treated with magnesium sulfate, filtered, and then concentrated under reduced pressure. The residue was isolated by column chromatography to obtain a title compound (2.9 g, yield: 80.0percent). [H NMR (500MHz,CD3OD) δ 8.12(d, 2H), 7.76(d, 1H), 7.37(d, 2H), 6.68(d, 1H), 2.43(s, 3H)
1.5 g With sodium hydroxide In water; acetone at 0 - 30℃; for 2 - 3 h; To a suspension of 2,4-dichloro-7H-pyrrolo[2,3-d] pyrimidine (l g, 0.005 mol) and toluene sulfonylchloride (1.3gm, 0.007) in 10 ml acetone cooled to about 0-5 °C , a solution of sodium hydroxide in water (0.32gm in 4ml water) was added slowly at about 0-5 °C .The temperature of the reaction mass was raised to 25-30 °C and stirred for 2-3 hrs. The progress of the reaction was monitored by TLC. After completion of the reaction the reaction mass was filtered and washed with a mixture of acetone and water. The solid was dried under vacuum at about 50-55 °C for about 10 hrs to afford 1.5 gm of 2,4-dichloro-7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3- d]pyrimidine as yellow colored solid. (HPLC purity >98.0percent)

Reference: [1] Patent: WO2010/38060, 2010, A1, . Location in patent: Page/Page column 68-69
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 1, p. 144 - 158
[3] Patent: WO2010/123919, 2010, A2, . Location in patent: Page/Page column 55
[4] Patent: WO2017/106771, 2017, A1, . Location in patent: Paragraph 00397
[5] Patent: WO2017/133667, 2017, A1, . Location in patent: Page/Page column 400
[6] Patent: WO2009/49028, 2009, A1, . Location in patent: Page/Page column 53
[7] Patent: WO2009/55674, 2009, A1, . Location in patent: Page/Page column 45-46
[8] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 10, p. 950 - 955
[9] Patent: CN106349224, 2017, A, . Location in patent: Paragraph 0107; 0108
[10] Patent: WO2017/97234, 2017, A1, . Location in patent: Paragraph 00364
[11] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 9, p. 1615 - 1620
[12] Patent: WO2018/4306, 2018, A1, . Location in patent: Page/Page column 31
[13] Patent: US2009/54425, 2009, A1, . Location in patent: Page/Page column 21
[14] Patent: WO2009/131687, 2009, A2, . Location in patent: Page/Page column 104
[15] Patent: WO2012/45195, 2012, A1, . Location in patent: Page/Page column 99-100
[16] Patent: WO2014/102826, 2014, A1, . Location in patent: Paragraph 0277
[17] Tetrahedron, 2014, vol. 70, # 33, p. 4947 - 4956
[18] Patent: WO2017/133667, 2017, A1, . Location in patent: Page/Page column 434
  • 2
  • [ 104-15-4 ]
  • [ 90213-66-4 ]
  • [ 934524-10-4 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With sodium hydride In tetrahydrofuran at 0 - 20℃;
Stage #2: at 20℃; for 18 h;
REFERENCE EXAMPLE 2 fR)-2-Choro-4-[3-(Λf,Wdimethy[amino)pyrrolidin-1-yl]-7-[(4-toiLfy.)suifony.- pyrτolo[2,3-d]pyrimidine a) 2,4-Dichloro-7-[(4-toiuyl)suJfonyI]-pyrro[o[2t3-d|pynmidine 6.39 g of NaH 60 percent (158 mmol) were slowly added at 0 0C over a 2,4-dichloro-7H- pyrrolo[2,3-d]pyrimidine solution (15 g, 78.9 mmol) in THF (300 mL). The reaction mixture was stirred at room temperature for 1 h. After this time p-toluensulfonyl chloride (16.4 g, 86 mmoi) was added and it was stirred at room temperature for 18 h. The solvent was evaporated to dryness, the crude product was diluted with H2O and extracted thrice with EtOAc. The combined organic phases were separated, dried over Na2SO4 and the solvent evaporated to dryness. The desired compound was obtained in quantitative yield and used without further purification. LC-MS (Method 1 ): tR = 2.72 min; m/z = 340 (MH").
Reference: [1] Patent: WO2010/34740, 2010, A1, . Location in patent: Page/Page column 67
  • 3
  • [ 934524-13-7 ]
  • [ 934524-10-4 ]
Reference: [1] Patent: WO2007/42298, 2007, A1, . Location in patent: Page/Page column 54-55
  • 4
  • [ 84955-31-7 ]
  • [ 934524-10-4 ]
Reference: [1] Patent: WO2012/45195, 2012, A1,
  • 5
  • [ 7355-55-7 ]
  • [ 934524-10-4 ]
Reference: [1] Patent: WO2012/45195, 2012, A1,
  • 6
  • [ 39929-79-8 ]
  • [ 934524-10-4 ]
Reference: [1] Tetrahedron, 2014, vol. 70, # 33, p. 4947 - 4956
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 934524-10-4 ]

Aryls

Chemical Structure| 896722-50-2

[ 896722-50-2 ]

6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.88

Chemical Structure| 479633-70-0

[ 479633-70-0 ]

4-Chloro-6-iodo-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.87

Chemical Structure| 252723-17-4

[ 252723-17-4 ]

5-Bromo-4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.86

Chemical Structure| 348640-02-8

[ 348640-02-8 ]

1-Tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.82

Chemical Structure| 1987286-78-1

[ 1987286-78-1 ]

Ethyl 4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate

Similarity: 0.80

Chlorides

Chemical Structure| 896722-50-2

[ 896722-50-2 ]

6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.88

Chemical Structure| 479633-70-0

[ 479633-70-0 ]

4-Chloro-6-iodo-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.87

Chemical Structure| 252723-17-4

[ 252723-17-4 ]

5-Bromo-4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.86

Chemical Structure| 1987286-78-1

[ 1987286-78-1 ]

Ethyl 4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate

Similarity: 0.80

Chemical Structure| 882562-40-5

[ 882562-40-5 ]

3-(2,5-Dichloropyrimidin-4-yl)-1-(phenylsulfonyl)-1H-indole

Similarity: 0.71

Sulfamides

Chemical Structure| 896722-50-2

[ 896722-50-2 ]

6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.88

Chemical Structure| 479633-70-0

[ 479633-70-0 ]

4-Chloro-6-iodo-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.87

Chemical Structure| 252723-17-4

[ 252723-17-4 ]

5-Bromo-4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.86

Chemical Structure| 348640-02-8

[ 348640-02-8 ]

1-Tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.82

Chemical Structure| 1987286-78-1

[ 1987286-78-1 ]

Ethyl 4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate

Similarity: 0.80

Related Parent Nucleus of
[ 934524-10-4 ]

Other Aromatic Heterocycles

Chemical Structure| 896722-50-2

[ 896722-50-2 ]

6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.88

Chemical Structure| 479633-70-0

[ 479633-70-0 ]

4-Chloro-6-iodo-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.87

Chemical Structure| 252723-17-4

[ 252723-17-4 ]

5-Bromo-4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.86

Chemical Structure| 348640-02-8

[ 348640-02-8 ]

1-Tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.82

Chemical Structure| 1987286-78-1

[ 1987286-78-1 ]

Ethyl 4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate

Similarity: 0.80